What is the appropriate weekly vitamin D3 dose for an otherwise healthy 11‑year‑old with a serum 25‑hydroxyvitamin D level of 17 ng/mL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vitamin D3 Weekly Dosing for an 11-Year-Old with Deficiency

For an 11-year-old with a serum 25-hydroxyvitamin D level of 17 ng/mL (deficiency), administer 50,000 IU of vitamin D3 once weekly for 8–12 weeks, followed by maintenance therapy of 1,000–2,000 IU daily. 1

Initial Loading Phase

  • Start with 50,000 IU of vitamin D3 (cholecalciferol) once weekly for 8–12 weeks to rapidly correct the deficiency, as this is the standard evidence-based loading regimen for pediatric and adolescent populations with documented deficiency. 1, 2, 3

  • Vitamin D3 is strongly preferred over vitamin D2 (ergocalciferol) because it maintains serum levels longer and has superior bioavailability, particularly important for intermittent (weekly) dosing schedules. 1, 4

  • A level of 17 ng/mL represents moderate deficiency (below the 20 ng/mL threshold), warranting an 8-week loading course; if the level were below 10 ng/mL (severe deficiency), extend the loading phase to 12 weeks. 1

  • The 50,000 IU weekly regimen has been validated in adolescents aged 13 ± 2 years and shown to safely and effectively raise 25(OH)D levels to the target range without adverse events. 2, 3

Maintenance Phase After Loading

  • Transition to 1,000–2,000 IU of vitamin D3 daily after completing the 8-week loading phase to maintain optimal levels and prevent recurrence. 1, 5, 4

  • For adolescents, a daily maintenance dose of 2,000 IU has been shown to raise 25(OH)D ≥20 ng/mL in 96% of subjects and ≥30 ng/mL in 64%, making it highly effective for this age group. 6

  • An alternative maintenance regimen is 50,000 IU once monthly (equivalent to approximately 1,600 IU daily), which can improve adherence if daily dosing is challenging. 1, 2

Target Serum Levels and Monitoring

  • The target serum 25(OH)D level is ≥30 ng/mL for optimal bone health, fracture prevention, and overall health benefits in growing adolescents. 1, 5, 4

  • Recheck serum 25(OH)D levels 3 months after starting supplementation (i.e., after completing the loading phase and initiating maintenance) to confirm adequate response and adjust dosing if needed. 1, 5, 4

  • If using weekly dosing, measure the level just prior to the next scheduled dose to accurately reflect trough concentrations. 1

  • The upper safety limit for serum 25(OH)D is 100 ng/mL; toxicity is extremely rare in pediatric populations with standard dosing regimens. 1, 5

Essential Co-Interventions

  • Ensure adequate calcium intake of 1,000–1,200 mg daily from diet plus supplements if needed, as vitamin D works synergistically with calcium for bone mineralization during adolescent growth. 1, 4, 3

  • Calcium supplements should be taken in divided doses of no more than 600 mg at once for optimal absorption. 1, 4

  • Administer vitamin D with the largest, fattiest meal of the day to maximize absorption, as it is a fat-soluble vitamin. 1

Special Considerations for Pediatric Populations

  • Adherence is typically 100% with weekly dosing in adolescents, making it a practical and effective regimen for this age group. 2

  • For children with malabsorption syndromes (e.g., inflammatory bowel disease, celiac disease, cystic fibrosis), consider higher oral doses (4,000–5,000 IU daily) or intramuscular administration if oral supplementation fails. 1, 5

  • Obese adolescents may require higher maintenance doses (up to 3,000–6,000 IU daily) due to sequestration of vitamin D in adipose tissue. 5

Critical Pitfalls to Avoid

  • Do not use active vitamin D analogs (calcitriol, alfacalcidol) to treat nutritional vitamin D deficiency, as they bypass normal regulatory mechanisms and increase hypercalcemia risk. 1, 4

  • Avoid single ultra-high loading doses (>300,000 IU) or annual mega-doses (≥500,000 IU), as they have been associated with adverse outcomes including increased falls and fractures, and are inefficient compared to weekly or daily dosing. 1, 5

  • Do not rely on 400 IU daily as initial treatment for documented deficiency, as this dose is insufficient to correct deficiency in a reasonable timeframe and will result in persistent low levels. 7, 6

  • Do not use sun exposure as a primary strategy for vitamin D repletion due to increased skin cancer risk and unreliable synthesis, especially in darker-skinned individuals. 5

Evidence-Based Dosing Algorithm

  1. Confirm deficiency: Serum 25(OH)D = 17 ng/mL (below 20 ng/mL threshold) 1
  2. Loading phase: 50,000 IU vitamin D3 once weekly × 8 weeks 1, 2, 3
  3. Maintenance phase: 1,000–2,000 IU vitamin D3 daily (or 50,000 IU monthly) 1, 5, 6
  4. Calcium co-supplementation: 1,000–1,200 mg daily in divided doses 1, 4, 3
  5. Monitoring: Recheck 25(OH)D at 3 months, target ≥30 ng/mL 1, 5, 4
  6. Long-term: Continue maintenance dosing and recheck annually once stable 1, 5

Expected Outcomes

  • The 50,000 IU weekly regimen typically raises 25(OH)D by approximately 40–70 ng/mL (16–28 ng/mL) over 8–12 weeks, which should bring the level from 17 ng/mL to at least 33–45 ng/mL if the patient is responding normally. 1

  • Using the rule of thumb that 1,000 IU daily increases serum 25(OH)D by approximately 10 ng/mL, a maintenance dose of 2,000 IU daily should sustain levels in the optimal 30–50 ng/mL range. 1, 5

  • Adherence with weekly dosing is excellent in adolescents, and adverse events are minor and rare with standard regimens. 2, 3

References

Guideline

Vitamin D Insufficiency Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Treatment of hypovitaminosis D in infants and toddlers.

The Journal of clinical endocrinology and metabolism, 2008

Guideline

Vitamin D3 Dosage for Depression with Vitamin D Deficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Vitamin D Supplementation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Vitamin D3 dose requirement to raise 25-hydroxyvitamin D to desirable levels in adolescents: results from a randomized controlled trial.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2014

Related Questions

What is the recommended treatment for a child with poor dentition, enamel hypoplasia, hypocalcemia, hypophosphatemia, and elevated alkaline phosphatase levels, is it Intravenous (IV) calcium gluconate or Vitamin D3 (Cholecalciferol) and calcium supplementation?
What is the recommended vitamin D (Vitamin D) dosing for adolescents?
What is the daily maximum vitamin D (International Units) intake for a 70-year-old woman?
Should a patient with a vitamin D level of 22 ng/mL continue or discontinue 1000 IU daily supplementation?
What is the appropriate treatment and monitoring plan for an elderly patient with severe vitamin D deficiency, prescribed 50,000 IU of vitamin D?
How does Zepbound (tirzepatide) help a patient with obstructive sleep apnea?
What is the appropriate work‑up and management for a healthy 55‑year‑old adult presenting with sudden transient amnesia lasting less than 24 hours, suspected transient global amnesia?
In a patient with bipolar disorder starting lamotrigine 25 mg daily, how soon should the dose be increased?
What is the appropriate surveillance colonoscopy interval for a patient with infrequent rectal bleeding who had a colonoscopy revealing a single tubular adenoma measuring 12 mm?
I have knee pain with radiating nerve pain down the leg, severe difficulty walking, a limp, and an apparent leg‑length discrepancy—what evaluation and treatment should I pursue?
What is the most likely diagnosis in a postmenopausal woman with low thyroid‑stimulating hormone, normal free thyroxine, elevated estradiol, and suppressed follicle‑stimulating hormone and luteinizing hormone?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.